Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venlafaxine and CBT for Anxiety in Alcoholism
NCT00248612Phase 3Completed
- Sponsor
- Boston Medical Center
- Start
- Sep 2003
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of venlafaxine in anxiety disorders and alcohol dependence (4 arms), sponsored by Boston Medical Center. Primary endpoints: Clinical Global Impression Scale-I at 11 weeks, Clinical Global Impression Scale-S at 11 weeks and 2 more. Started Sep 2003; status: completed.
02
Drugs
venlafaxine
03
Conditions
anxiety disordersalcohol dependence
Beyond the preview
Go deeper on NCT00248612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00248612.